226 related articles for article (PubMed ID: 28256556)
1. An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.
Choi K; Komurov K; Fletcher JS; Jousma E; Cancelas JA; Wu J; Ratner N
Sci Rep; 2017 Mar; 7():43315. PubMed ID: 28256556
[TBL] [Abstract][Full Text] [Related]
2. Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.
Prada CE; Jousma E; Rizvi TA; Wu J; Dunn RS; Mayes DA; Cancelas JA; Dombi E; Kim MO; West BL; Bollag G; Ratner N
Acta Neuropathol; 2013 Jan; 125(1):159-68. PubMed ID: 23099891
[TBL] [Abstract][Full Text] [Related]
3. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
4. Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.
Wu J; Keng VW; Patmore DM; Kendall JJ; Patel AV; Jousma E; Jessen WJ; Choi K; Tschida BR; Silverstein KA; Fan D; Schwartz EB; Fuchs JR; Zou Y; Kim MO; Dombi E; Levy DE; Huang G; Cancelas JA; Stemmer-Rachamimov AO; Spinner RJ; Largaespada DA; Ratner N
Cell Rep; 2016 Mar; 14(8):1979-90. PubMed ID: 26904939
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
Nebesio TD; Ming W; Chen S; Clegg T; Yuan J; Yang Y; Estwick SA; Li Y; Li X; Hingtgen CM; Yang FC
Glia; 2007 Apr; 55(5):527-36. PubMed ID: 17236191
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.
Kazmi SJ; Byer SJ; Eckert JM; Turk AN; Huijbregts RP; Brossier NM; Grizzle WE; Mikhail FM; Roth KA; Carroll SL
Am J Pathol; 2013 Mar; 182(3):646-67. PubMed ID: 23321323
[TBL] [Abstract][Full Text] [Related]
7. Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.
Muir D; Neubauer D; Lim IT; Yachnis AT; Wallace MR
Am J Pathol; 2001 Feb; 158(2):501-13. PubMed ID: 11159187
[TBL] [Abstract][Full Text] [Related]
8. P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
Patritti Cram J; Wu J; Coover RA; Rizvi TA; Chaney KE; Ravindran R; Cancelas JA; Spinner RJ; Ratner N
Elife; 2022 Mar; 11():. PubMed ID: 35311647
[TBL] [Abstract][Full Text] [Related]
9. Injury signals cooperate with Nf1 loss to relieve the tumor-suppressive environment of adult peripheral nerve.
Ribeiro S; Napoli I; White IJ; Parrinello S; Flanagan AM; Suter U; Parada LF; Lloyd AC
Cell Rep; 2013 Oct; 5(1):126-36. PubMed ID: 24075988
[TBL] [Abstract][Full Text] [Related]
10. The role of nerve microenvironment for neurofibroma development.
Liao CP; Pradhan S; Chen Z; Patel AJ; Booker RC; Le LQ
Oncotarget; 2016 Sep; 7(38):61500-61508. PubMed ID: 27517146
[TBL] [Abstract][Full Text] [Related]
11. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
[TBL] [Abstract][Full Text] [Related]
12. Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.
Ling BC; Wu J; Miller SJ; Monk KR; Shamekh R; Rizvi TA; Decourten-Myers G; Vogel KS; DeClue JE; Ratner N
Cancer Cell; 2005 Jan; 7(1):65-75. PubMed ID: 15652750
[TBL] [Abstract][Full Text] [Related]
13. EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation.
Wu J; Liu W; Williams JP; Ratner N
Oncogene; 2017 Mar; 36(12):1669-1677. PubMed ID: 27748759
[TBL] [Abstract][Full Text] [Related]
14. Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.
Mo J; Anastasaki C; Chen Z; Shipman T; Papke J; Yin K; Gutmann DH; Le LQ
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108355
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK.
Na Y; Hall A; Choi K; Hu L; Rose J; Coover RA; Miller A; Hennigan RF; Dombi E; Kim MO; Subramanian S; Ratner N; Wu J
Oncogene; 2021 Feb; 40(5):951-963. PubMed ID: 33293695
[TBL] [Abstract][Full Text] [Related]
16. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
17. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations.
Serra E; Rosenbaum T; Winner U; Aledo R; Ars E; Estivill X; Lenard HG; Lázaro C
Hum Mol Genet; 2000 Dec; 9(20):3055-64. PubMed ID: 11115850
[TBL] [Abstract][Full Text] [Related]
18. PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors.
Keng VW; Rahrmann EP; Watson AL; Tschida BR; Moertel CL; Jessen WJ; Rizvi TA; Collins MH; Ratner N; Largaespada DA
Cancer Res; 2012 Jul; 72(13):3405-13. PubMed ID: 22700876
[TBL] [Abstract][Full Text] [Related]
19. STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.
Fletcher JS; Springer MG; Choi K; Jousma E; Rizvi TA; Dombi E; Kim MO; Wu J; Ratner N
Oncogene; 2019 Apr; 38(15):2876-2884. PubMed ID: 30542122
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.
Yang FC; Ingram DA; Chen S; Hingtgen CM; Ratner N; Monk KR; Clegg T; White H; Mead L; Wenning MJ; Williams DA; Kapur R; Atkinson SJ; Clapp DW
J Clin Invest; 2003 Dec; 112(12):1851-61. PubMed ID: 14679180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]